enGene Therapeutics Inc
ENGN
NASDAQ
Biotechnology
$1.70
USD
+0.01 (+0.59%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $113.21M
Volume 918.7K
Price Target
$4.00 – $4.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $4.00 and a min estimate of $4.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$4.00
-$6.9 vs prior
Implied Upside
+135.3%
-407.1% vs prior
Analyst Covering
1
-5 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
14%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Judah Frommer | Morgan Stanley | Sell | Downgraded | 1 month ago | Plus | Plus | Plus |
Andres Y. Maldonado | HC Wainwright & Co. | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
